MedTrace Logo

An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System

NCT04210622 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-05-16

Study results available
· View outcomes & findings →

Summary

A prospective, single-arm, multi-center, safety and performance assessment of the Sphere-9™ Catheter and the Affera Mapping and Ablation System to treat Atrial Arrhythmias

Conditions

Interventions

DEVICE

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-07-04
Completion
2020-06-18

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04210622 on ClinicalTrials.gov